The House voted 230 to 201 on Friday to pass a continuing resolution (CR) — swiftly signed into law by President Biden — funding the federal government through Dec. 16 and reauthorizing the FDA’s user fee agreements.
Source: Drug Industry Daily
The House voted 230 to 201 on Friday to pass a continuing resolution (CR) — swiftly signed into law by President Biden — funding the federal government through Dec. 16 and reauthorizing the FDA’s user fee agreements.
Source: Drug Industry Daily